| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 61.9305 | 66 |
| GSM780708 | Untreated after 4 days (C2_1) | 54.9727 | 59 |
| GSM780709 | Untreated after 4 days (C3_1) | 52.51 | 55 |
| GSM780719 | Untreated after 4 days (C1_2) | 51.2873 | 52 |
| GSM780720 | Untreated after 4 days (C2_2) | 51.9891 | 54 |
| GSM780721 | Untreated after 4 days (C3_2) | 50.7106 | 51 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 58.8489 | 64 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 53.2423 | 57 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 48.5695 | 43 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 50.4908 | 50 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 50.1189 | 49 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 49.806 | 48 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 50.0948 | 49 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 51.222 | 52 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 52.1868 | 54 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 50.4079 | 50 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 53.7186 | 57 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 55.5953 | 60 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 41.3794 | 11 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 57.7447 | 63 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 53.6979 | 57 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 48.6767 | 44 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 54.1276 | 58 |